SEARCH WITHIN CONTENT
VOLUME 14 , ISSUE 2 ( May-August, 2022 ) > List of Articles
Roma Pradhan, Mallika Dhanda, Navya M Kurian, Priya Singh, Saumya Singh, Nasim Ahmad, Nidhi Anand
Keywords : Differentiated thyroid cancer, Endocrine surgery, Thyroid
Citation Information : Pradhan R, Dhanda M, Kurian NM, Singh P, Singh S, Ahmad N, Anand N. Use of Lenvatinib in Neoadjuvant Setting to Achieve Total Thyroidectomy in a Case of Inoperable Follicular Thyroid Carcinoma. World J Endoc Surg 2022; 14 (2):66-67.
License: CC BY-NC 4.0
Published Online: 15-04-2023
Copyright Statement: Copyright © 2022; The Author(s).
Lenvatinib and other tyrosine kinase inhibitors (TKIs) are being used in locally advanced thyroid cancers like poorly differentiated and anaplastic, as well as in radiorefractory differentiated thyroid cancer (DTC). However, their role in the neoadjuvant setting for DTCs is being increasingly explored, but there are only anecdotal reports in the literature that too only for percutaneous transhepatic cholangiography (PTC). Our case seems to be the first case where it was used in follicular thyroid cancer in the neoadjuvant setting.